Preventing Post-ERCP Pancreatitis: The Role of Prophylactic Pancreatic Duct Stenting in the Rectal NSAID Era

BACKGROUND: Rectal non-steroidal anti-inflammatory drug at endoscopic retrograde cholangiopancreatography is now the standard of care to reduce the risk of post-ERCP pancreatitis. Pancreatic duct stenting also reduces the risk of post- ERCP pancreatitis in high-risk patients, but failed pancreatic d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JOP
Autores principales: Bekkali, Noor-L-Houda, Thomas, Tom, Keane, Margaret Geraldine, Murray, Sam, Joshi, Deepak, Elsayed, Ghassan, Johnson, Gavin James, Chapman, Michael Huw, Pereira, Stephen Paul, Webster, George John Mitchell
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5933872/
https://ncbi.nlm.nih.gov/pubmed/29731700
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares